Fosun International Recognized for ESG Excellence and Healthcare Innovations

Fosun International Limited, a leading company listed on the Hong Kong Stock Exchange, has recently been honored for its exceptional performance in environmental, social, and governance (ESG) practices. The company's dedication to sustainability and responsible business practices has earned it a spot on the prestigious 2024 China ESG Impact List by Fortune China magazine.

Fortune China's recognition underscores the increasing importance of ESG principles for companies striving to enhance their long-term competitiveness, particularly in today's challenging economic climate. Fosun International, alongside industry giants like Alibaba, JD.com, and Lenovo, has been lauded for its initiatives in environmental conservation, employee well-being, and community engagement.

With a steadfast commitment to sustainable development, Fosun International has integrated the United Nations Global Compact principles into its corporate strategy. The company's efforts have garnered accolades, including an impressive MSCI ESG rating of AA and inclusion in esteemed sustainability indices such as the Hang Seng Corporate Sustainability Index and FTSE4Good Index Series.

In addition to its ESG achievements, Fosun International has made significant advancements in the healthcare sector, particularly in the development of groundbreaking drugs for cancer and malaria treatment. Notable contributions include the approval of HANSIZHUANG for lung cancer therapy and the prequalification of artesunate for severe malaria patients, showcasing the company's positive impact on global healthcare.

Looking ahead, Fosun International remains steadfast in its commitment to advancing sustainable development goals, fostering technological innovation, and supporting philanthropic endeavors. Leveraging its extensive global industrial network, the company aims to create a lasting positive influence on society and continue its journey towards a more sustainable future.